drugset / Trial / NCT06329037
The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study
RandomizedParallel-groupDouble-blindBasic science
Summary
The main aim of the present study is to investigate the effects of orally administered vasopressin (AVP) on bottom-up and top-down attentional control to socio-emotional stimuli by combining a validated saccade/antisaccade eye-tracking paradigm with a randomized between-subject placebo-controlled pharmacological trial design.
Timeline
- Start
- 2024-03-05
- Primary completion
- 2025-06-01
- Completion
- 2025-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vasopressin | Peptide | 20 iu | Oral |
Indications
No indication recorded.